Depression and Anxiety Trial, Recruiting (NCT07637773)

Depression and Anxiety Trial, Recruiting NCT07637773 Sponsor: Jie Li Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07637773 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been formally assessed and confirmed to have a diagnosis of major depressive disorder according to standardised diagnostic guidelines (DSM-5), using a structured clinical interview
People aged 60 years or older (any gender)
People whose depression has been rated as severe based on a score above 24 on a standard depression rating scale called the Hamilton Depression Scale (HAMD-17)

Who may not be able to join:

People with a history of serious head injury or significant neurological conditions such as epilepsy
People who have any devices or implants in the brain, such as cochlear implants or aneurysm clips
People who have previously received certain brain stimulation treatments, such as transcranial direct current stimulation (tDCS) (confirm with trial site)
People who have undergone certain other brain or physical stimulation therapies in the 8 weeks before joining, including treatments such as non-convulsive electroconvulsive therapy, repetitive transcranial magnetic stimulation, or transcranial direct current stimulation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 88188876

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07637773

Sponsor: Jie Li

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: +86 88188876

More information: https://clinicaltrials.gov/study/NCT07637773

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been formally assessed and confirmed to have a diagnosis of major depressive disorder according to standardised diagnostic guidelines (DSM-5), using a structured clinical interview
People aged 60 years or older (any gender)
People whose depression has been rated as severe based on a score above 24 on a standard depression rating scale called the Hamilton Depression Scale (HAMD-17)

Who may not be able to join:

People with a history of serious head injury or significant neurological conditions such as epilepsy
People who have any devices or implants in the brain, such as cochlear implants or aneurysm clips
People who have previously received certain brain stimulation treatments, such as transcranial direct current stimulation (tDCS) (confirm with trial site)
People who have undergone certain other brain or physical stimulation therapies in the 8 weeks before joining, including treatments such as non-convulsive electroconvulsive therapy, repetitive transcranial magnetic stimulation, or transcranial direct current stimulation

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jie Li

Registry

ClinicalTrials.gov

Start date

16 March 2026

Est. completion

31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Dimensional Anhedonia Rating Scale (DARS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov